MEDESIS : Invest Securities confirms its recommendation
Invest Securities confirms its neutral recommendation on the stock, with a target price of E3.3.
' Exactly 1 month ago, the company announced that the Montpellier Commercial Court had handed down a verdict in favor of Bpifrance, ordering Medesis
to pay E1.4m to Bpifrance ' recalls Invest Securities.
At the time, the company announced its intention to negotiate with Bpifrance management to identify a suitable repayment plan, but it seems that its intentions have changed, probably as a result of the discussions held. Medesis
now intends to appeal in order to obtain a reversal of the Court's decision, and to avoid the payment of 1.4mE, which represents a significant sum on the scale of Medesis' indicates the research firm.
Copyright (c) 2023 CercleFinance.com. All rights reserved.
The information and analyses published by Cercle Finance are intended solely as a decision-making aid for investors. Cercle Finance cannot be held responsible, directly or indirectly, for the use of information and analyses by readers. Uninformed investors are advised to consult a professional advisor before investing. This information does not constitute an invitation to sell or a solicitation to buy.
Go to the original article.
Contact us to request a correction